Biohit Oyj Managers' Transactions

Report this content

23 February 2021 at 10.00 am local time (EET)

Biohit Oyj: Managers' Transactions
Person subject to the notification requirement
Name:                                    Semi Korpela
Position:                                Chief Executive Officer

Issuer:                                   Biohit Oyj
LEI:                                        74370089ATTSNBXJVT29

Notification type:                 INITIAL NOTIFICATION
Reference number:              74370089ATTSNBXJVT29_20210222152942_7

Transaction date:                 2021-02-19
Venue:                                   NASDAQ HELSINKI LTD (XHEL)

Nature of the transaction:    DISPOSAL
Instrument type:                    SHARE


ISIN:                                        FI0009005482

Transaction details
Unit price: 2.
1559 EUR

Aggregated transactions
Volume weighted average price: 2.
1559 EUR

Biohit Oyj

Semi Korpela

For additional information: 
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.